Advanced search
Publication Cover
Renal Failure Volume 29, 2007 - Issue 3
Submit an article Journal homepage
560
Views
25
CrossRef citations to date
0
Altmetric
Clinical Study

Low Dose Intradermal Vaccination Is Superior to High Dose Intramuscular Vaccination for Hepatitis B in Unresponsive Hemodialysis Patients

Hasan Micozkadioglu Department of Nephrology, Başkent University Faculty of Medicine, Hospital of Adana, Adana, TurkeyCorrespondence[email protected]
,
Aysegul Zumrutdal Department of Nephrology, Başkent University Faculty of Medicine, Hospital of Adana, Adana, Turkey
,
Dilek Torun Department of Nephrology, Başkent University Faculty of Medicine, Hospital of Adana, Adana, Turkey
,
Siren Sezer Department of Nephrology, Başkent University Faculty of Medicine, Hospital of Adana, Adana, Turkey
,
Fatma Nurhan Ozdemir Department of Nephrology, Başkent University Faculty of Medicine, Hospital of Adana, Adana, Turkey
&
Mehmet Haberal Department of General Surgery, Başkent University Faculty of Medicine, Hospital of Adana, Adana, Turkey
Pages 285-288 | Published online: 07 Jul 2009

REFERENCES

  • Tong NK, Beran J, Kee SA, Miguel JL, Sanchez C, Bayas JM, et al. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int. 2005; 68(5)2298–2303
  • Liu YL, Kao MT, Huang CC. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis. Vaccine 2005; 23: 3957–3960
  • Ozdemir FN, Micozkadioglu H, Arat Z, Turan M, Gulmus S, Haberal M. The importance of A3 allele in response to hepatitis B vaccine in end-stage renal disease patients. Transplant Proc. 2004; 36(9)2615–2617
  • Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med. 1995; 332(16)1065–1069
  • Sezer S, Ozdemir FN, Guz G, Arat Z, Colak T, Sengul S, et al. Factors influencing response to hepatitis B virus vaccination in hemodialysis patients. Transplant Proc. 2000; 32(3)607–608
  • Caillat-Zucman S, Gimenez JJ, Wambergue F, Albouze G, Lebkiri B, Naret C, et al. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int. 1998; 53(6)1626–1630
  • McNulty CA, Bowen JK, Williams AJ. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules. Vaccine 2005; 23(32)4142–4147
  • Chau KF, Cheng YL, Tsang DN, Choi KS, Wong KM, Chak WL, et al. Efficacy and side effects of intradermal hepatitis B vaccination in CAPD patients: a comparison with the intramuscular vaccination. Am J Kidney Dis. 2004; 43(5)910–917
  • Propst T, Propst A, Lhotta K, Vogel W, Konig P. Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am J Kidney Dis. 1998; 32(6)1041–1045
  • Verkade MA, van de Wetering J, Klepper M, Vaessen LM, Weimar W, Betjes MG. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients. Kidney Int. 2004; 66(2)614–621
  • Roozbeh J, Moini M, Lankarani KB, Sagheb MM, Shahpoori S, Bastani B. Low dose intradermal versus high dose intramuscular hepatitis B vaccination in patients on chronic hemodialysis. ASAIO J. 2005; 51(3)242–245
  • Argani H, Akhtari E. Levamizol enhances immune responsiveness of intradermal and intramuscular hepatitis B vaccination in hemodialysis patients. J Immune Based Ther Vaccines. 2006; 4(1)3
  • Sonmez E, Sonmez AS, Bayindir Y, Coskun D, Ariturk S. Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals. Vaccine 2002; 21(3–4)243–246
  • DaRoza G, Loewen A, Djurdjev O, Love J, Kempston C, Burnett S, et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better.Am J Kidney Dis. 2003; 42(6)1184–1192
  • Saab S, Weston SR, Ly D, Brezina M, Yee HF, Jr, Han SH, Gitnick G. Comparison of the cost and effectiveness of two strategies for maintaining hepatitis B immunity in hemodialysis patients. Vaccine 2002; 20(25–26)3230–3235
  • Fabrizi F, Andrulli S, Bacchini G, Corti M, Locatelli F. Intradermal versus intramuscular hepatitis B re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation. Nephrol Dial Transplant. 1997; 12(6)1204–1211

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.